Homocysteine Bibliography of free accessible medical and biological reviews

Nr.	Year OPEN	Title	rate good	rate bad	no link	Citation
1	1999	Homocyst(e)ine, atherosclerosis, and thrombosis.	+	-	nl	South Med J 92(9):858-65 (1999)
2	1996	Homocysteine and cardiovascular disease.	+	-	nl	QJM 89(8):561-3 (1996)
3	1998	Hyperhomocysteinemia and atherosclerotic vascular disease: pathophysiology, screening, and treatment. off.	+	-	nl	Arch Intern Med 158(12):1301-6 (1998)
4	2004	Homocysteine: is it a clinically important cardiovascular risk factor?	+	-	nl	Cleve Clin J Med 71(9):729-34 (2004)
5	2000	Homocysteine, B vitamins, and risk of cardiovascular disease.	+	-	nl	Heart 83(2):127-30 (2000)
6	1999	Homocysteine, hypertension and stroke.	+	-	nl	J Hum Hypertens 13(5):289-93 (1999)
7	2008	The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis.	+	-	nl	BMC Cardiovasc Disord 8(-):24 (2008)
8	2002	Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease.	+	-	nl	Pharmacol Rev 54(4):599-618 (2002)
9	2003	Homocysteine and methylmalonic acid in diagnosis and risk assessment from infancy to adolescence.	+	-	nl	Am J Clin Nutr 78(1):7-21 (2003)
10	1992	The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine.	+	-	nl	Am J Clin Nutr 55(1):131-8 (1992)
11	2008	Cardiovascular pathogenesis in hyperhomocysteinemia.	+	-	nl	Asia Pac J Clin Nutr 17(1):8-16 (2008)
12	2004	Methylation demand: a key determinant of homocysteine metabolism.	+	-	nl	Acta Biochim Pol 51(2):405-13 (2004)
13	2008	Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk.	+	-	nl	J Appl Genet 49(3):267-82 (2008)
14	2006	Biochemistry of homocysteine in health and diseases.	+	-	nl	Indian J Biochem Biophys 43(5):275-83 (2006)
15	2005	Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.	+	-	nl	J Thromb Haemost 3(2):292-9 (2005)
16	2006	PPAR-gamma agonists decrease hyperhomcysteinemia and cardiac dysfunction: new hope for ailing diabetic hearts?	+	-	nl	Am J Physiol Heart Circ Physiol 291(1):H26-8 (2006) Rocic P
17	2000	Homocysteine and neurologic disease.	+	-	nl	Arch Neurol 57(10):1422-7 (2000)
18	1997	Homocysteine and thrombotic disease.	+	-	nl	Blood 90(1):1-11 (1997)
19	2009	Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.	+	-	nl	Eur Heart J 30(1):6-15 (2009)
20	1997	Mild hyperhomocysteinemia and arterial occlusive disease.	+	-	nl	Haematologica 82(2):129-32 (1997)
21	2004	Death receptor induced apoptosis: a new mechanism of homocysteine-mediated endothelial cell cytotoxicity.	+	-	nl	Hypertension 43(6):1168-70 (2004)
22	2001	The kidney and homocysteine metabolism.	+	-	nl	J Am Soc Nephrol 12(10):2181-9 (2001)
23	1999	Hyperhomocysteinemia in chronic renal disease.	+	-	nl	J Am Soc Nephrol 10(4):891-900 (1999)
24	1997	Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes.	+	-	nl	Kidney Int 52(1):10-20 (1997)
25	1999	Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosis.	+	-	nl	Endocr Rev 20(5):738-59 (1999)
26	2004	Cystathionine beta-synthase: structure, function, regulation, and location of homocystinuria-causing mutations.	+	-	nl	J Biol Chem 279(29):29871-4 (2004)
27	2010	Genetics of homocysteine metabolism and associated disorders.	+	-	nl	Braz J Med Biol Res 43(1):1-7 (2010)
28	2008	Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis.	+	-	nl	Mayo Clin Proc 83(11):1203-12 (2008) Humphrey LL
29	2003	Homocysteine, a proinflammatory and proatherosclerotic factor: role of intracellular reactive oxygen species.	+	-	nl	Circ Res 93(4):271-3 (2003) Schini-Kerth VB
30	2008	Hyperhomocysteinemia and occlusive vascular disease: an emergent role for fibroblast growth factor 2.	+	-	nl	Circ Res 102(8):869-70 (2008) Medina MA
31	2007	Homocysteinylation of metallothionein impairs intracellular redox homeostasis: the enemy within!	+	-	nl	Arterioscler Thromb Vasc Biol 27(1):8-11 (2007) Colgan SM
32	2008	Mechanisms of homocysteine-induced glomerular injury and sclerosis.	+	-	nl	Am J Nephrol 28(2):254-64 (2008)
33	2006	Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?	+	-	nl	Nephrol Dial Transplant 21(5):1161-6 (2006)
34	2004	Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.	+	-	nl	Cell Death Differ 11 Suppl 1():S56-64 (2004) Austin RC
35	2003	Hyperhomocysteinemia--case report.	+	-	nl	Rev Port Cardiol 22(2):223-30 (2003)
36	2007	Homocysteine and cardiovascular risk: considering the evidence in the context of study design, folate fortification, and statistical power.	+	-	nl	Clin Chem 53(5):807-9 (2007) Ueland PM
37	2004	Clinical usefulness of plasma homocysteine in vascular disease.	+	-	nl	Med J Aust 181(6):314-8 (2004)
38	2007	Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels.	+	-	nl	Vasc Health Risk Manag 3(1):99-108 (2007)
39	2006	MTHFR 677 TT genotype and hyperhomocysteinaemia: an underestimated risk TANDEM for patients with stroke.	+	-	nl	J Neurol Neurosurg Psychiatry 77(10):1103 (2006) Caso V

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.